Gemcitabine, dexamethasone, and cisplatin (GDP) as salvage chemotherapy for patients with relapsed or refractory peripheral T cell lymphoma—not otherwise specified

Fei Qi, Mei Dong, Xiaohui He, Ye‐Xiong Li, Weihu Wang, Peng Liu, Jianliang Yang, Lin Gui, Changgong Zhang, Sheng Yang, Shengyu Zhou, Yuankai ShiAnnals 2016 · DOI

BibTeX
@article{qi2016gemcitabine,
  author = {Fei Qi and Mei Dong and Xiaohui He and Ye‐Xiong Li and Weihu Wang and Peng Liu and Jianliang Yang and Lin Gui and Changgong Zhang and Sheng Yang and Shengyu Zhou and Yuankai Shi},
  title = {{Gemcitabine, dexamethasone, and cisplatin (GDP) as salvage chemotherapy for patients with relapsed or refractory peripheral T cell lymphoma—not otherwise specified}},
  journal = {Annals},
  year = {2016},
  doi = {10.1007/s00277-016-2877-6},
}

Loading related content...

Figure